NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
16 hedge funds and large institutions have $9.62M invested in NeuBase Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$7.68M | |
2 | +$218K | |
3 | +$72.3K | |
4 |
VF
Virtu Financial
New York
|
+$64K |
5 |
HWA
Heritage Wealth Advisors
Richmond,
Virginia
|
+$54K |